Related Experiment Videos
[Rhinocerebral mucormycosis: apropos of 4 new Tunisian cases]
F Makni1, F Cheikh-Rouhou, A Ayadi
1Laboratoire de parasitologie-mycologie, CHU H. Bourguiba, Sfax, Tunisie.
Abstract:
Mucormycosis is a rare opportunistic infection but a fulminant disease. We report the 4 first cases of rhinocerebral mucormycosis diagnosed in Sfax region (Tunisia). They occurred in insulin dependent diabetes and developed varying clinical manifestations from facial cellulites to ocular and cerebral extension. The diagnosis of mucormycosis was not initially evoked, but confirmed tardively by anatomopathologic and mycologic examinations. The evolution was favourable in 2 cases by administration of amphotericine B associated with extensive surgical debridement and correction of the diabetes. Two patients had a fatal outcome. This infection has a severe prognosis and necessitates early diagnosis.
Insights
This study details four cases of rhinocerebral mucormycosis in Tunisian diabetics. Early diagnosis and treatment, including amphotericin B and surgery, are crucial for favorable outcomes in this severe opportunistic infection.
Area of Science:
- Medicine
- Infectious Diseases
- Mycology
Background:
- Mucormycosis is a rare but aggressive opportunistic fungal infection.
- Rhinocerebral mucormycosis is a particularly severe form, often affecting immunocompromised individuals.
- Diabetes mellitus is a significant risk factor for invasive fungal infections.
Observation:
- Four cases of rhinocerebral mucormycosis were diagnosed in the Sfax region, Tunisia.
- All patients had insulin-dependent diabetes mellitus.
- Clinical presentations varied from facial cellulitis to ocular and cerebral involvement.
Findings:
- Diagnosis was often delayed, requiring anatomopathologic and mycologic confirmation.
- Treatment involved amphotericin B, extensive surgical debridement, and diabetes management.
- Two out of four patients experienced a fatal outcome, highlighting the infection's severity.
Implications:
- Early diagnosis of mucormycosis is critical for improving patient survival rates.
- Integrated management including antifungal therapy, surgery, and glycemic control is essential.
- This case series underscores the need for heightened awareness of mucormycosis in diabetic patients, especially in endemic regions.
Related Concept Videos
Cryptococcal Meningitis
Fungal Group Zygomycota
Toxoplasmosis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: